H3 K27M Glioma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Oral ONC201 in Adult Recurrent Glioblastoma (NCT02525692) | Jazz Pharmaceuticals | 2016-01-01 |
Track H3 K27M Glioma automatically
Every clearance here is in the API, with alerts when new ones post.